Indian RAS system SSi Mantra comes to Indonesia
SS Innovations, an India-based developerper of the surgical robot technologies, recently received regulatory approval from the Indonesian Ministry of Health for its flagship robot-assisted surgery system.
It also announced that the SSi Mantra was recently installed at the private Baidya and Banskota Hospital in Nepal, possibly the first installation of a surgical robotic system in the country.
Developed as an affordable solution, SSi Mantra features a modular robotic arm, a vision cart with 3D 4K vision and a command center with an open console design. With applications in various specialties such as general surgery, cardiothoracic surgery and urological surgery, this RAS system has been clinically validated in more than 70 types of surgical procedures.
THE BIG TREND
Such as SS Innovations ais awaiting regulatory approval for its RAS system in the United States and Europe next year, but is actively pursuing expansion across Asia. Demand for robotic surgery is reportedly increasing in the region as alternatives to expensive market-leading solutions finally appear on the market. In India, for example, robotic surgery is becoming an option in public hospitals. Hospitals outside the major cities also want to offer robotic surgeries.
Some healthcare institutions have begun testing the feasibility of robotic telesurgery procedure that combines telemedicine and RAS. The National University Hospital in Singapore and Fujita Health University in Japan collaborated last October to perform a remote gastrectomy on a simulated stomach from a distance of more than 5,000 kilometers.
In Indonesia, the local government collaborated with Iran in May last year to test the Robotic Telesurgery Center project in Bandung and Yogyakarta. After a successful run, they expanded their coverage to the country’s western and eastern islands at the beginning of this year.
“With the arrival of the SSi Mantra in the Indonesian market, we believe we can play an important role in increasing access to and reducing the cost of robotic surgery options,” said Dr. Sudhir Srivastava, Chairman and CEO of SS Innovation, on their entry into the Indonesian market. market.
According to ResearchAndMarkets, the global surgical robotics market, which was worth $79 billion in 2022, is expected to grow to nearly $190 billion by 2032, with a CAGR of 9.1%.
In other news, SS Innovations recently unveiled the latest version of the SSi Mantra. The SSi Mantra 3 now comes with five slimmer robot arms and a 3D HD headset. This launch took place alongside the announcement of the first human telesurgery trial using the SSi Mantra. A cholecystectomy was performed in Gurugram between World Laparoscopy Hospital and SS Innovations headquarters over a distance of 5 km, powered by Airtel’s fiber optic network.